Medical Oncologist
CION Cancer Clinics
Ovarian cancer surveillance: why it falls short for carriers | CION Cancer Clinics
Ovarian surveillance works poorly because no current test finds ovarian cancer early enough to save lives. CA-125 and internal ultrasound usually detect it only after it has spread. This page explains why, what each test can and cannot do, how ovarian screening compares with breast screening in carriers, and which symptoms should send you to a doctor promptly. At CION Cancer Clinics, our team helps carriers and their families plan checks, next steps and support after a genetic result.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why can't ovarian cancer be caught early with screening?
- What tests are used, and where does each one fall short?
- How does ovarian cancer usually grow in a carrier?
- What do the words about ovarian screening mean?
- How does ovarian screening compare with breast screening in carriers?
- What this page cannot tell you
- What do women and families get wrong about ovarian screening?
- Common questions about ovarian surveillance
The short answer
Why can't ovarian cancer be caught early with screening?
Because no test yet finds it early enough to save lives. The two tests available, a CA-125 blood test and an internal ultrasound, usually pick up ovarian cancer only after it has spread. Large studies have not shown that screening with them lowers deaths. That is why guidelines do not treat ovarian surveillance as a safe alternative to other options for high-risk women.
Where ovarian cancer really starts
The most common type in carriers of BRCA and similar faults often begins in the fallopian tube, not the ovary. It sheds cells into the abdomen early, while the first growth is still tiny. An ultrasound is looking for a lump in the ovary. By the time one appears, the cancer has often already moved on.
Why this is different from breast or bowel checks
Bowel cancer passes through a polyp stage that a camera can see and remove. Breast cancer can be seen on an MRI while it is still small. Ovarian cancer has no such visible stage that current tests can find reliably. That gap, not a lack of effort, is why the results are poor.
A normal ovarian screening result offers much less reassurance than a normal breast MRI.The tests on offer
What tests are used, and where does each one fall short?
Each test has a real use. None of them, alone or together, does the job that women hope for.
CA-125 blood test
Measures a protein that many ovarian cancers release. Early cancers often do not raise it, and many harmless conditions do, including periods, pregnancy, fibroids and endometriosis.
Also raised by
- Tuberculosis in the abdomen, still seen in India
- Liver disease and fluid in the abdomen
- Pelvic infection
Internal ultrasound
A probe placed in the vagina gives a close view of the ovaries. It is good at showing cysts, which are very common and mostly harmless. It cannot see a tiny cancer in the fallopian tube or cells scattered in the abdomen.
Both tests together
Research programmes have tracked CA-125 over time and added an ultrasound when it rose. Some found cancers at a less advanced stage. None has yet shown clearly that this saves lives in high-risk women.
Knowing your symptoms
Bloating that does not go away, feeling full quickly, pain in the tummy or pelvis and needing to pass urine more often. If these are new and happen most days, see a doctor promptly rather than waiting for a scheduled check.
Not sure whether this applies to you?
Ask an oncologistWhy timing is the problem
How does ovarian cancer usually grow in a carrier?
-
A tiny change in the fallopian tube
In many carriers, the first abnormal cells appear in the lining at the far end of the tube. They are too small for any scan to see.
-
Cells shed into the abdomen
The tube opens into the abdomen, so these cells can drift out early. They can settle on the ovary and on the thin lining of the abdomen.
-
Growth with few clear symptoms
The abdomen has plenty of space, so small deposits cause little discomfort. Early symptoms, if any, are vague and easily blamed on gas or acidity.
-
Tests finally change
CA-125 rises or a lump appears on ultrasound. By this point, in many women, the cancer is already outside the ovary.
-
Which is why prevention leads the plan
Because watching finds it late, most high-risk plans focus on lowering the risk itself. Removing the tubes and ovaries is the most effective option. Surveillance, if used, is a bridge until that decision.
On your report
What do the words about ovarian screening mean?
- CA-125
- A protein measured in a blood test. A raised level is a reason to look further, not a diagnosis. A normal level does not rule cancer out.
- Transvaginal ultrasound
- An ultrasound done with a slim probe inside the vagina. It gives a clearer view of the ovaries and womb than a scan over the tummy.
- High-grade serous cancer
- The most common type of ovarian cancer in BRCA carriers. It tends to grow and spread quickly, which is why screening struggles.
- STIC
- Short for a very early cancer change in the fallopian tube lining. It is usually found only when the tube is removed and examined.
- Stage shift
- Finding a cancer at an earlier stage than without screening. It is encouraging, but it does not always mean more lives are saved.
- Risk-reducing surgery
- Removing the tubes and ovaries before any cancer appears, to lower the risk sharply. It is one option among several and is discussed separately.
Side by side
How does ovarian screening compare with breast screening in carriers?
Breast screening
Ovarian screening
Breast MRI finds most cancers while small
No test reliably finds ovarian cancer early
A clear scan is genuinely reassuring
A normal result offers limited reassurance
Recommended by major guidelines for carriers
Not recommended as a substitute for surgery
Can continue safely for many years
Mainly a short bridge, if used at all
Surgery is one choice among equals
Surgery is the option with the strongest evidence
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
What this page cannot tell you
It cannot tell you when, or whether, to have surgery. That depends on which gene you carry, your age, whether you want more children and your own health. BRCA1 carriers are generally advised to consider it earlier than BRCA2 carriers, and other genes have their own timing. Your gynaecologic oncologist and genetic counsellor will set that out with you.
It cannot interpret your CA-125 result
A single raised value can have many harmless causes, and a normal one does not settle the question. What your specific gene result means is a question for the counsellor who ordered the test.
Who this does not apply to
Most women do not carry a high-risk gene, and routine ovarian screening is not recommended for them. Women whose tubes and ovaries have already been removed do not need these checks. Newer approaches, such as removing the tubes first and the ovaries later, are still being studied, and the evidence so far is limited.
Choosing not to have surgery yet is a real decision. If you make it, agree a plan for symptoms and a date to talk again.Commonly believed
What do women and families get wrong about ovarian screening?
"My CA-125 is normal, so I do not have ovarian cancer."
Many early ovarian cancers do not raise CA-125. A normal result is not a clear bill of health, and new symptoms still need checking whatever the last test said.
"A yearly ultrasound is as good as surgery."
It is not. An ultrasound looks for a lump that usually appears late. Removing the tubes and ovaries lowers the risk itself, which no scan can do.
"A raised CA-125 means cancer."
Periods, fibroids, endometriosis, pregnancy, liver disease and abdominal tuberculosis can all raise it. A raised value means a closer look is needed, nothing more yet.
"Ovarian cancer is silent, so there is nothing to watch for."
Symptoms are vague, not absent. Bloating, early fullness and pelvic pain that are new and happen most days deserve a prompt visit, and saying you carry a gene fault helps the doctor act quickly.
Questions we are asked
Common questions about ovarian surveillance
If it works poorly, why do some doctors still offer it?
Some women are not ready for surgery, perhaps because they want children first. For them, a doctor may offer CA-125 and ultrasound for a limited time while they decide. It is a bridge, and both of you should be clear that it is not a substitute for lowering the risk.
Should I have CA-125 tests while I decide about surgery?
That is a choice to make with your gynaecologic oncologist. Some women find the checks reassuring. Others find the false alarms stressful. Either way, agree how often the tests will be done, what happens after a raised result, and when you will talk about surgery again.
My CA-125 came back raised. What happens now?
Usually the test is repeated, often with an ultrasound, and your doctor looks for other causes such as your period, fibroids or infection. Most raised results in carriers without symptoms turn out to be harmless. Do not assume the worst before the repeat test is done.
Which symptoms should I not ignore?
Bloating that does not go away, feeling full after eating very little, pain in the tummy or pelvis, and needing to pass urine more often. If these are new and happen most days, see a doctor promptly and mention that you carry a gene fault.
Does the contraceptive pill lower ovarian risk?
Studies suggest the pill lowers ovarian cancer risk in carriers as it does in other women. Whether it suits you depends on your breast cancer risk and your general health. Discuss it with your team rather than starting or stopping it on your own.
When should I think about removing my ovaries?
Usually once you have completed your family, with timing that depends on your gene. BRCA1 carriers are generally advised to consider it earlier than BRCA2 carriers. Your team will explain the timing for your gene and what surgery means for menopause and bones.
Would an MRI or a PET scan work better?
No. These scans are used to investigate symptoms or stage a known cancer. They have not been shown to find early ovarian cancer in women without symptoms, and they bring their own false alarms, cost and, for PET, radiation.
Who can help me weigh my options?
A genetic counsellor and a gynaecologic oncologist together are the right people. They can set surgery, the pill and symptom awareness side by side for your gene and your plans. If you are not sure who to approach, call the CION helpline.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- National Cancer Institute — Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ) - Patient Version
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- GeneReviews (NCBI Bookshelf) — Hereditary Breast and Ovarian Cancer Syndrome
- NHS — Ovarian cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
HBOC management across a lifetimeWhere ovarian decisions fit in the wider planWeighing the three optionsSurveillance, medicines and surgery set side by sideThe contraceptive pill and ovarian riskWhat the pill can and cannot do for carriersHRT after ovary removalManaging early menopause after surgery
Talk to us
Trying to decide between checks and surgery?
Tell us which gene you carry and where you are in your plans. We will help you arrange time with a genetic counsellor and a gynaecologic oncologist to weigh the options. One helpline serves every CION centre.